Unilab Case Analysis
April 10, 2010 – CORPORATE SOCIAL RESPONSIBILITY OF UNITED LABORATORIES, INC. (UNILAB)
OBJECTIVES:
Their primary goal is to develop, manufacture and market a wide range of prescription and consumer health products covering all major therapeutic categories. Many of these products are now leading brands in the Philippines, Indonesia, Thailand, Malaysia, Singapore, Hong Kong, Vietnam and Myanmar. Unilab operates strategically located manufacturing facilities throughout Southeast Asia, linked to extensive and expanding market coverage and technical support. The major Unilab manufacturing complex in Metro Manila, (the Philippines is the region's largest and most significant pharmaceutical market) has been cited by international health organizations, as one of the finest is Asia. Construction has already begun on a new complex, which will exceed the current facility in both scale and technical capability, clear evidence of the company's unswerving commitment to excellence and continuing improvement. Unilab has developed significant technical and marketing alliances with major multinational pharmaceutical companies and research organizations based in the United States, Europe and Japan. Growing international involvement, a broader regional role and more diverse operational activities are underpinned by a committed and highly trained work force. It is therefore from a platform of strength and with an ethos of integrity that Unilab confidently views the challenge of delivering broad-based health care into a dynamically changing Asia in the 21st century.
The Vision Deliver the best value in health care. Our products are a vital part of every Filipino family’s full enjoyment of life.
The Mission Work together to make healthcare products even better for a healthier Filipino family
The Corporate Culture Unilab’s corporate symbol is the “Bayanihan”, the tradition of working together and sharing the fruits of common endeavor, is the reason for UNILAB’s
OBJECTIVES:
Their primary goal is to develop, manufacture and market a wide range of prescription and consumer health products covering all major therapeutic categories. Many of these products are now leading brands in the Philippines, Indonesia, Thailand, Malaysia, Singapore, Hong Kong, Vietnam and Myanmar. Unilab operates strategically located manufacturing facilities throughout Southeast Asia, linked to extensive and expanding market coverage and technical support. The major Unilab manufacturing complex in Metro Manila, (the Philippines is the region's largest and most significant pharmaceutical market) has been cited by international health organizations, as one of the finest is Asia. Construction has already begun on a new complex, which will exceed the current facility in both scale and technical capability, clear evidence of the company's unswerving commitment to excellence and continuing improvement. Unilab has developed significant technical and marketing alliances with major multinational pharmaceutical companies and research organizations based in the United States, Europe and Japan. Growing international involvement, a broader regional role and more diverse operational activities are underpinned by a committed and highly trained work force. It is therefore from a platform of strength and with an ethos of integrity that Unilab confidently views the challenge of delivering broad-based health care into a dynamically changing Asia in the 21st century.
The Vision Deliver the best value in health care. Our products are a vital part of every Filipino family’s full enjoyment of life.
The Mission Work together to make healthcare products even better for a healthier Filipino family
The Corporate Culture Unilab’s corporate symbol is the “Bayanihan”, the tradition of working together and sharing the fruits of common endeavor, is the reason for UNILAB’s